The global Sternal Closure Systems market is projected to reach US$ 3.79 billion by 2030, growing at a CAGR of 5.6%
Factors driving the growth of the sternal closure systems market include mounting convenience of medical reimbursements in key markets, high-tech developments in sternotomy procedures, and increased elderly population with a number of operating procedures.
Sternal dehiscence adds to major morbidity and mortality after sternotomy. The major causes of sternal dehiscence include cough, chronic obstructive pulmonary disease, sternal fracture, osteoporosis, morbid obesity, and sternal devascularization from internal mammary artery harvesting. Sternal dehiscence invariably leads to additional surgical procedures and may be life-threatening when associated with mediastinitis and sepsis.
Regionally, North America accounted for the largest market share of the global sternal closure systems market attributable to high cardiac diseases. Leading players of the global sternal closure systems market include Depuy Synthes, KLS Martin Group, Zimmer Biomet, Orthofix Holdings, Inc., Jace Medical, LLC, A&E Medical Corporation, Acute Innovations, Kinamed Incorporated, Abyrx, Inc., among others.
Sternal Closure Systems Market Scope
|Revenue forecast in 2030
|US$ 3.79 billion
|CAGR of 5.6 % during 2020-2030
|By Product, By Application, Region.
|North America, Europe, Asia Pacific, South America, Middle East and Africa
|Key Players Profiled
|Kinamed Incorporated, Immunogen Inc., Seattle Genetics Inc., A&E Medical, Orthofix Holdings Inc., Takeda Pharmaceutical Company Limited, Zimmer Biomet Holdings Inc., Depuy Synthes, Pfizer Inc., Acute Innovations, KLS Martin Group, Hoffman-La Roche Ltd., Bayer Healthcare Pharmaceuticals, Novartis AG, etc.
Key segments of the global sternal closure systems market
- Closure devices
- Bone cement
- Median sternotomy
- Bilateral thoracosternotomy
- Stainless steel
- North America
- United Kingdom
- Asia Pacific
- South America
- Middle East & Africa
- South Africa
Reasons for the study
- Booming of technological advancements in the emerging markets
- Growing geriatric population, which is more susceptible to chronic CVDs
- Growing availability of medical reimbursements across major markets
What does the report include?
- The study on the global sternal closure systems market includes qualitative factors such as drivers, restraints and opportunities
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product, procedure, and material.. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global sternal closure systems market is suitable for all the players across the value chain including product manufacturing companies, suppliers/distributors, R&D labs, CROs, healthcare organizations, medical reimbursement and insurance providers
- Venture capitalists and investors looking for more information on the future outlook of the global sternal closure systems market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global sternal closure systems market
Frequently Asked Questions (FAQ) :
Sternal instability due to suboptimal sternal closure is problematic, causing pain, infection, disability, and increased costs. The determinants of sternal instability are so inextricably intertwined that it is difficult to single out what led to the sternal instability in the first place. These determinants could be related to the patient, procedure, surgical technique, or hardware. Because patient- and procedure-related factors cannot easily be controlled, emphasis has been placed on optimizing surgical technique and developing a plethora of novel sternal closure platforms. The ideal sternal closure system would be simple, fast, reproducible, radio-opaque, durable, and easily removable in an emergency or redo operation, free of infection risks, cost-effective, and able to provide rigid stable fixation.
Based on procedure, the median sternotomy segment is expected to be the fastest-growing segment by 2028. Median sternotomy is the preferred approach for most cardiac operations and for resection of mediastinal masses. Although the complication rate after median sternotomy is low (0.5%-5%), the mortality of sternal dehiscence, mediastinitis, and osteomyelitis exceeds 50%. Median stemotomy offers several advantages over other incisions for elective pulmonary resection. Compared with posterolateral thoracotomy, median sternotomy is associated with less postoperative pain and with quicker physical recovery and discharge from the hospital, and may extend pulmonary resection to certain patients with reduced pulmonary function who might not tolerate lateral thoracotomy.
Asia-Pacific is set to grow at the highest CAGR for sternal closure systems by 2028. Many of the global low and middle income countries (LMICs) are experiencing an epidemiological evolution. By means of a development in socioeconomic conditions, the epidemiological change has steered the rise of non-communicable ailments particularly cardiovascular diseases (CVDs). CVDs have emerged as the principal causes of death worldwide. In 2016, more than 75% of the 17.9 million deaths from CVDs occurred in LMICs. Ischaemic heart disease and cerebrovascular disease are accountable for the massive cardiovascular deaths in LMICs. Though exhaustive international efforts to avert and treat cardiovascular deaths in many countries are underway sternal complications are probable to upsurge in these nations.